JPMorgan Assumes BridgeBio Pharma (BBIO) at Overweight

February 22, 2021 1:55 AM EST
Get Alerts BBIO Hot Sheet
Price: $59.50 +0.25%

Rating Summary:
    11 Buy, 1 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 11 | Down: 5 | New: 41
Trade Now! 
Join SI Premium – FREE

JPMorgan analyst Anupam Rama assumes coverage on BridgeBio Pharma (NASDAQ: BBIO) with a Overweight rating and a price target of $78.00.

For an analyst ratings summary and ratings history on BridgeBio Pharma click here. For more ratings news on BridgeBio Pharma click here.

Shares of BridgeBio Pharma closed at $66.68 yesterday.

You May Also Be Interested In

Related Categories

New Coverage